Author

M. Coker

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:metagenomics· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:machine learning (classical)· 1 Approach:statistical model· 1

Frequent Co-Authors

C. E. Price· 2 shared G. O'Toole· 2 shared J. C. Madan· 2 shared K. Barrack· 2 shared R. Valls· 2 shared T. H. Hampton· 2 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

C. E. Price

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Predicting Clinical Outcomes in Infants With Cystic Fibrosis From Stool Microbiota using Random Forest Algorithms

R. Valls, T. H. Hampton, C. E. Price, K. Barrack, G. O'Toole, M. Coker, J. C. Madan

This paper uses random forest algorithms to predict clinical outcomes in children with cystic fibrosis based on stool microbiota composition.

bioRxiv · Aug 6, 2022 · PreprintMicrobiology

Development of the Intestinal Microbiome in Cystic Fibrosis in Early Life

C. E. Price, T. H. Hampton, R. Valls, K. Barrack, G. O'Toole, J. C. Madan, M. Coker

This study tracks the development of the gut microbiome in children with cystic fibrosis from birth to age 4, finding persistent dysbiosis and early signs of inflammatory bowel disease-associated microbiota.

bioRxiv · May 27, 2022Microbiology